The outlook of companies tied to the drug's past presents a intricate investment picture . While the initial boom generated substantial profits , generic copies have significantly impacted sales . Investing in related pharmaceutical companies now requires a thorough assessment of proprietary safeguards, evolving medical trends , and the potential f